#Global #Recombinant #Vaccines #Market #Expected #Reach
Portland, OR, Oct. 21, 2022 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global Recombinant Vaccines Market generated $8.1 billion in 2021 and is estimated to hit $24.7 billion by 2031, registering a CAGR of 11.4% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario. The report is a helpful source of information for leading market players, new entrants, investors, and stakeholders in devising strategies for the future and taking steps to strengthen their position in the market.
Download Free Sample Report (258 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/18055
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2022–2031 |
| Market Size in 2031 | $24.7 billion |
| CAGR | 11.4% |
| No. of Pages in Report | 258 |
| Drivers | Increase in research and development activities for recombinant vaccines |
| Rise in prevalence of infectious and zoonotic diseases | |
| Emerging technologies for developing vaccines | |
| Surge in number of product approvals | |
| Opportunities | The high growth potential in untapped emerging economies |
Covid-19 scenario-
- The Covid-19 pandemic positively impacted the recombinant vaccines market. The introduction of Covid-19 vaccines was a major step toward reducing the spread of the virus and the associated disease and deaths. Governments across the world ensured seamless delivery of Covid-19 recombinant vaccines to the prioritized group.
- For the vaccine development, the World Health Organization (WHO) facilitated the collaboration and accelerated efforts on an unprecedented scale and convened vital communications across the research communities. The increase in the research and development activities proved to be beneficial for the development of effective vaccines.
- Moreover, the advantageous effects of vaccination on the population facilitated the…
Read on GNW: Global Recombinant Vaccines Market Is Expected to Reach
